Back to results
US 2020/0048340 A1Published application
Anti-il-33 antibodies and uses thereof
AssigneeEli Lilly and Company
InventorsRobert Jan Benschop, Julian Davies, Angela Jeannine Okragly, Chetankumar Natvarlal Patel, Stephanie Marie Truhlar
Life of this patent
Estimating the term…
Abstract
Antibodies which bind and neutralize human IL-33, and methods of using same, are provided, said antibodies are useful as agents for treating conditions associated with allergic disease including treating atopic dermatitis.
Claims6
1-19. (canceled)
A DNA molecule comprising a polynucleotide sequence encoding an antibody heavy chain (HC), wherein the HC comprises an amino acid sequence given by SEQ ID NO:
- 9.
Dependencies are inferred from the claim text.